Compassion Mental Health Services is adding transcranial magnetic stimulation therapy to its behavioral health treatments.
According to the provider, transcranial magnetic stimulation — or TMS — is one of the most advanced methods for treating clinical depression, especially for treatment-resistant adults suffering from depression who have not experienced full recovery from medication- based therapies.
Able to be performed as an outpatient procedure, TMS therapy does not require any anesthesia or sedation. Using a magnetic coil, NeuroStar’s TMS therapy system generates highly concentrated magnetic fields that rapidly turn on and off. The electrical currents generated as a result activate cells in the brain thought to release neurotransmitters such as serotonin, norepinephrine, and dopamine.
TMS can restore the balance of those neurotransmitters and, in turn, relieve depression, according to Compassion Mental Health Services, which adds that at least 60 percent of people with depression who have not benefited from medications have experienced a clinically meaningful response by using TMS.
“We’re excited to offer this cutting-edge medical technology to adults struggling with treatment-
resistant depression,” said Dr. Santiago A. Almanzar, founder and CEO of CMHS. “Our practice is committed to continuing to provide the latest in mental health treatments, and offering NeuroStar’s TMS therapy is an important step in that direction.”
According to the National Institute of Mental Health, an estimated 17.3 million adults, or 7.1 percent of all adults, in the United States have had at least one major depressive episode. On the global scale, more than 300 million people worldwide are estimated to have depression. For more information, contact Compassion Mental Health Services at (724) 856-8620 or visit https://compassionmhs. com/tms-therapy.
The article was published in the New Castle News on July 25, 2019.